Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of CPE mRNA | decreases expression | 12419474
|
D000111 |
Acetylcysteine |
Acetylcysteine results in decreased expression of CPE mRNA | decreases expression | 16084531
|
D019386 |
Alendronate |
Alendronate affects the expression of CPE mRNA | affects expression | 16079270
|
D001104 |
Arbutin |
Arbutin results in increased expression of CPE mRNA | increases expression | 17103032
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of CPE mRNA | decreases expression | 19128835
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CPE mRNA | affects cotreatment|increases expression | 18164116
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CPE mRNA | increases expression | 20382639
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of CPE mRNA | decreases expression | 12075121
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of CPE mRNA | decreases expression | 12419474
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of CPE mRNA | increases expression | 15336504
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of CPE mRNA | increases expression | 17484886
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CPE mRNA | affects cotreatment|increases expression | 18164116
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate results in decreased expression of CPE mRNA | decreases expression | 16084531
|
D004958 |
Estradiol |
Estradiol affects the expression of CPE mRNA | affects expression | 14699072
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CPE mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of CPE mRNA | increases expression | 19619570
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of CPE mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of CPE mRNA | decreases expression | 16174780 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of CPE mRNA | affects cotreatment|decreases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of CPE mRNA | affects expression | 16079270 17351261
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of CPE mRNA | decreases expression | 12075121 17557909 16174780
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of CPE mRNA | increases expression | 18035473
|
D005472 |
Fluorouracil |
CPE protein affects the susceptibility to Fluorouracil | affects response to substance | 15352031
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of CPE protein | increases expression | 15352031
|
D019833 |
Genistein |
Genistein results in decreased expression of CPE mRNA | decreases expression | 12075121
|
C051890 |
irinotecan |
irinotecan analog results in increased expression of CPE mRNA | increases expression | 18927307
|
C011890 |
kojic acid |
kojic acid results in increased expression of CPE mRNA | increases expression | 16595896
|
D016210 |
Methacholine Chloride |
CPE gene mutant form results in increased susceptibility to Methacholine Chloride | increases response to substance | 16002559
|
D009020 |
Morphine |
Morphine results in increased expression of CPE mRNA | increases expression | 20144693
|
D010126 |
Ozone |
CPE gene mutant form promotes the reaction [Ozone results in increased expression of CCL2 protein] | increases expression|increases reaction | 16002559
|
D010126 |
Ozone |
CPE gene mutant form promotes the reaction [Ozone results in increased expression of CXCL1 protein] | increases expression|increases reaction | 16002559
|
D010126 |
Ozone |
CPE gene mutant form promotes the reaction [Ozone results in increased expression of CXCL2 protein] | increases expression|increases reaction | 16002559
|
D010126 |
Ozone |
CPE gene mutant form promotes the reaction [Ozone results in increased expression of IL6 protein] | increases expression|increases reaction | 16002559
|
D010126 |
Ozone |
CPE gene mutant form results in increased susceptibility to Ozone | increases response to substance | 16002559
|
D010126 |
Ozone |
Ozone results in decreased expression of CPE mRNA | decreases expression | 12763052
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CPE mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of CPE mRNA | increases expression | 19482888
|
D010795 |
Phthalic Acids |
Phthalic Acids results in increased expression of CPE mRNA | increases expression | 15728792
|
D020849 |
Raloxifene |
Raloxifene affects the expression of CPE mRNA | affects expression | 16079270
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of CPE mRNA | affects expression | 14699072
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of CPE mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CPE mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CPE mRNA | decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of CPE mRNA | affects cotreatment|decreases expression | 17942748
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CPE mRNA | increases expression | 16604517
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.30 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
7.48 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.48 | 14514962 15322242 11752688 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.69 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
12.85 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
12.85 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
12.85 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
12.85 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
12.85 | 11473722 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
6.41 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.41 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
15.91 | 16434500 19052882 19061943 17162532 18056438 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
15.91 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
15.91 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.36 | 17451421 17308373 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.42 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.18 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
4.18 | 15800139 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
3.95 | 10965797 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
7.97 | 17963324 16511603 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.97 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.22 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.71 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.71 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.46 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.46 | 16292516 |
MESH:D001249 |
Asthma |
|
epigallocatechin gallate |
7.59 | 16516891 |
MESH:D001249 |
Asthma |
|
Ozone |
7.59 | 16373670 17854713 |
MESH:D001249 |
Asthma |
|
Tretinoin |
7.59 | 16456186 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Phthalic Acids |
4.20 | 20106747 |
MESH:D001327 |
Autoimmune Diseases |
|
epigallocatechin gallate |
4.82 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.17 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
14.06 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.06 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
14.06 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.54 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.61 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.64 | 11985600 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.23 | 16580743 |
MESH:D002545 |
Brain Ischemia |
|
Morphine |
4.90 | 19211983 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
5.58 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
5.58 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
5.58 | 12948864 16675129 17289903 19861407 18497071 17261762 17018787 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
5.58 | 15136595 16110121 19217205 18608205 16595493 16557594 18357371 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
5.58 | 17200150 16541309 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
5.58 | 15775269 16912660 15758505 17595753 17242785 16837676 17049068 15572757 17261762 17952589 17893378 17440819 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
5.58 | 19142967 15668708 19103187 19155303 18351453 15565566 16202921 19084267 19059307 19189210 16273361 20859285 18855134 11161223 16873071 18815881 20005174 19200415 19487384 20135344 17049068 18629630 18425577 19011961 16818667 21152245 17440819 19221464 19244106 19288272 20390343 17893378 18997820 19189212 18821012 20544844 19289846 19115204 20065188 17261762 19410462 17242785 21138602 18984771 19066611 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
5.58 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
5.58 | 16873071 16443354 16166294 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.49 | 18417511 15516495 17626835 18315731 14754758 19059883 16777450 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.34 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.10 | 11589617 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.49 | 16183385 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.22 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.54 | 15700767 16097048 15721981 18705752 15673190 16124888 16227642 16192424 3786805 16011737 10355542 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.42 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
7.55 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.55 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.26 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.91 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
19.08 | 16217749 14691202 15553829 15073043 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
19.08 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
19.08 | 16807293 16878318 19052882 17173139 18393292 16288022 20935162 10672840 3084413 20514400 18210153 17055752 19394651 17138121 19701751 19171122 20084675 18506893 18785209 17978847 19335982 19539802 3581430 19208518 19519916 17761372 17428255 18788625 16935385 19919837 16502159 18978308 18494052 20524982 19418558 16830150 20214788 20101231 21159647 16569478 19383236 19107877 20432363 17162532 16328049 16779866 20727157 20512989 18971187 16698587 18056438 11831363 19822196 18665156 20007298 10737359 18691550 16681979 16540662 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
19.08 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
19.08 | 16799960 17045692 17088986 18930000 17971768 16332177 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
19.08 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
19.08 | 20935162 20007298 17173139 1701930 6705139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
19.08 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
19.08 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.74 | 17123778 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.63 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
2.90 | 18695887 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.90 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
7.25 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
7.25 | 18986760 16280240 16757204 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.25 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.79 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.79 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.23 | 16120746 18850075 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
6.94 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
6.94 | 15775269 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.95 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
14.70 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
14.70 | 18226522 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
14.70 | 21159647 2727394 7505956 17174075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
14.70 | 18566989 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.01 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.34 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.64 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.64 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.70 | 15861022 17333356 17110522 16105132 16919318 17681005 11677210 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.91 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.42 | 12621046 8697196 15668235 15340226 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.42 | 9407595 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.38 | 15800139 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.46 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
5.63 | 16340194 17725105 17018589 16510598 18772588 15001691 17287894 17016597 17172411 17169374 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
5.63 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
5.63 | 17287894 17725105 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
3.38 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
3.38 | 17594712 18288408 17695437 18949393 16524972 17016601 17255274 15289873 18802399 17401013 18448328 17454858 16391804 15148649 14970324 16331619 17094418 18383874 16303861 18509181 16282729 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
3.38 | 16303861 16391804 17454858 18259882 18509181 17159606 15273666 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.85 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.95 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.60 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.60 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.60 | 16925845 8800419 9224671 9125849 10589399 9211117 14991402 9142499 17551590 9664655 |
MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
4.16 | 19747007 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.54 | 16733453 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.87 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.12 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.96 | 17474826 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
9.76 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
epigallocatechin gallate |
9.76 | 16988119 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
9.76 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
9.76 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
13.83 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
13.83 | 17308373 17451421 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
13.83 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Morphine |
4.29 | 2540324 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
8.39 | 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
8.39 | 11566570 6884620 19336974 2869522 10092053 6623471 7179309 15968718 15027814 15998439 16177239 7440962 9327722 17522070 4309450 3786805 16227642 21278145 7120509 10915739 3732212 19085960 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
8.39 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.39 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.58 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.78 | 1851702 |
MESH:D004487 |
Edema |
|
Raloxifene |
6.13 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.13 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.11 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.11 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
13.99 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
13.99 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
13.99 | 19031437 |
MESH:D004700 |
Endocrine System Diseases |
marker/mechanism |
|
| 15358678 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.34 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
16.47 | 19148513 18566989 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
16.47 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
16.47 | 19155303 17893378 16202921 20544844 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
16.47 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.81 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.87 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.62 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.77 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.34 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.01 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.77 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.87 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.88 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
6.88 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
6.88 | 15173087 16337965 16785472 16481741 17638652 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.24 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.24 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
27.85 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
27.85 | 15959796 19224547 17595544 61145 12795759 16239168 12631006 16045604 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
27.85 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
27.85 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
27.85 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
27.85 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.09 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.21 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.28 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.94 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
13.36 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.36 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
13.36 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.03 | 16904648 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
6.68 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.68 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.77 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.34 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
7.25 | 18337622 15162350 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.25 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.91 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.11 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.11 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.37 | 11110106 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.12 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.36 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
7.64 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.64 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.78 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.50 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.80 | 16354765 15340226 18606429 16959395 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Alendronate |
7.73 | 16769263 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.73 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.28 | 16899240 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.33 | 16778211 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
4.91 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.91 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.85 | 15338365 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.57 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.23 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.33 | 17937319 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
14.54 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
14.54 | 17296493 |
MESH:D007249 |
Inflammation |
|
Methacholine Chloride |
14.54 | 18249437 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
14.54 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
14.54 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
marker/mechanism |
|
| 15358678 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
6.91 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.91 | 16393666 16627594 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.53 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.20 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.20 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.45 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.31 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
11.31 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
11.31 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.27 | 16973256 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
9.79 | 15070760 |
MESH:D007938 |
Leukemia |
|
Genistein |
9.79 | 17468513 18980019 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
9.79 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.58 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.06 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.25 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
8.74 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
8.74 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.72 | 19850784 16968895 16467208 20471514 17050201 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.72 | 17596541 16294345 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
7.11 | 17869043 17107899 15622746 16966277 16330433 19642359 12679006 15213294 17217047 16823087 12712474 11468182 12018890 16112521 17712046 19035177 9834237 11161223 16331271 19075265 15336539 19225113 15748426 16891316 17649720 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.11 | 19035177 17294898 17217047 9834237 17107899 16788101 19642359 17649720 17368321 17361223 17339181 16823087 16331271 16891316 16935935 19075265 16766008 17506722 17301526 17712046 19029980 12679006 16140955 19225113 15748426 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.12 | 16882451 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.13 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.98 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
10.24 | 16239168 16943688 21278145 16221502 11903743 11408273 17157831 17174718 17334410 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
10.24 | 18665156 18407596 20032147 19638242 18522880 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
10.24 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
10.43 | 15057751 12741479 17565644 17766677 16015684 15996030 20821823 15362042 14716496 17525996 15893842 17721639 15650968 18279442 18705752 18156304 12666154 15123356 17944888 14716833 18481824 17976157 18166357 12667390 18317297 15052691 11481614 18376398 14724832 15876570 17823541 18418968 16116963 18187930 18395914 17640975 18472094 16011737 18006644 17714472 15370692 12445421 14512876 16192424 15730626 15818738 14620537 18263696 12546737 10355542 12649538 15959796 15673190 16027843 15925388 17631135 17557913 18205269 17869086 18395095 18472332 12632512 17481882 18429990 12898905 12958196 12632514 12609069 14748882 18339082 17698563 16097048 17922224 13678700 16136751 17900296 17761835 18420326 16638106 12586293 17805973 16033810 15338365 18251166 18412020 17708605 18054572 15931870 12389079 16248980 18210741 12445418 18277467 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
epigallocatechin gallate |
10.43 | 17481882 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
10.43 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
10.43 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
10.43 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
10.43 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
10.43 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
6.15 | 16246199 16964402 15830285 17285989 15720792 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.15 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
6.15 | 19363144 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.92 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.48 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
24.31 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
24.31 | 21295105 19389873 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
24.31 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
24.31 | 18648771 15175105 19833225 19812893 2862719 19690152 20434301 12112319 19642983 20452335 19427195 19254457 20101389 21278145 21167192 19499222 19090486 19638242 20501860 12771043 19996281 20137499 19551842 21047994 15885732 10737359 19073162 19426721 2422723 20405173 20583210 18644402 21071580 19256749 18978307 20492335 19850985 9163691 20118626 18754104 19294768 19255062 18977376 16942905 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
24.31 | 15113037 18383874 16603448 17045692 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
24.31 | 19073162 19482888 15975961 8742319 19812893 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
24.31 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
24.31 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
25.94 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
25.94 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
25.94 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
25.94 | 19539802 3124819 18775883 17942915 18544905 18093689 18079962 18253720 19009564 17174075 16267830 18164116 17854601 19519916 16842330 21159647 9362446 2563599 18282651 19004024 18308698 19126423 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
kojic acid |
25.94 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
25.94 | 1399818 17172636 6150874 18308698 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
25.94 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.17 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
7.30 | 12815614 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
7.30 | 8266340 19066396 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.61 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
8.14 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
8.14 | 6695378 21163286 20512841 20970405 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
8.14 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
8.14 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
8.14 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.14 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.54 | 15086387 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.51 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.07 | 16891317 11807958 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
9.07 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
9.07 | 19196723 11731420 19196722 14580682 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.81 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.81 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.69 | 17453147 |
MESH:D008545 |
Melanoma |
|
epigallocatechin gallate |
4.96 | 11746506 17992120 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
4.96 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
4.96 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.94 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.18 | 16940565 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.86 | 10496685 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.30 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.45 | 18986760 16757204 |
MESH:D052016 |
Mucositis |
|
irinotecan |
4.76 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
6.84 | 15949261 19417148 14977855 19549372 11468182 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
6.84 | 16497877 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
epigallocatechin gallate |
5.24 | 17962980 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.42 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
6.93 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.93 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.76 | 17141266 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.83 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.89 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
7.89 | 17141266 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.23 | 17484760 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.30 | 16343187 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.73 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
12.83 | 14720322 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
12.83 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
12.83 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
12.83 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.44 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
4.75 | 16928823 18600527 18239605 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
4.75 | 16594593 16946489 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.75 | 19196722 19189210 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.49 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
28.23 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
28.23 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
28.23 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
28.23 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
28.23 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
11.35 | 19446573 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
11.35 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
11.35 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.35 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.14 | 20387270 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.48 | 8761367 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.87 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.27 | 16436463 |
MESH:D009765 |
Obesity |
marker/mechanism |
|
| 15358678 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.12 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Alendronate |
11.23 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
11.23 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
11.23 | 17882678 15775268 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
9.38 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
9.38 | 15579764 17823083 17893378 15758505 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.74 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
10.64 | 16624393 19769630 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.64 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
10.64 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
10.64 | 16936753 |
MESH:D010146 |
Pain |
|
Morphine |
6.60 | 18699797 16273134 15215642 20225289 6776300 15275824 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.60 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
15.36 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
15.36 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
15.36 | 16500647 16929163 15113037 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
15.36 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
15.36 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.46 | 11578682 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.93 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.00 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.89 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
5.25 | 11550810 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.15 | 18929643 18381685 18007984 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.32 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.41 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
8.41 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
8.69 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.69 | 11896295 11399792 11222880 11118676 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.82 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.82 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.06 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.06 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.06 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.06 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.06 | 16925846 15256057 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.06 | 16536755 16220300 15731164 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.06 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.38 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.07 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.25 | 12752131 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.55 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.54 | 10548101 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.30 | 15770314 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.80 | 18722050 18286688 15538739 16160472 |
MESH:D015427 |
Reperfusion Injury |
|
Morphine |
4.01 | 19211983 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
4.30 | 12210543 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.60 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.87 | 16116481 16283617 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.73 | 16646077 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.53 | 4039156 3137016 16876388 11442880 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.57 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
8.75 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.75 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
8.75 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.73 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.73 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.79 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
6.12 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
6.12 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
6.12 | 16424979 15786421 17522103 17172411 18396642 19084572 18567086 16951190 17498489 19015929 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
6.12 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
6.12 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
3.78 | 17918041 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.63 | 16837676 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.74 | 16045194 16684133 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.39 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.95 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.65 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
15.58 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
15.58 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
15.58 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
15.58 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
12.88 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
12.88 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
9.12 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.12 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.72 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.08 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
7.82 | 20435036 11780464 12973940 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
7.82 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
7.82 | 17572228 8653321 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
8.74 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.74 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.76 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.06 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.36 | 16752155 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.34 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.96 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.32 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.82 | 16761959 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.30 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.00 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.76 | 16287080 |